Bloomberg Intelligence cover image

Robinhood Credit Card, Boeing Shuffle

Bloomberg Intelligence

00:00

Exploring Novo Nordisk's Production Ramp-Up and Future Developments in Pharma

This chapter discusses Novo Nordisk's production ramp-up for medications like Wigovi and Ozempik, market approvals for oral gel p1s, opportunities for mergers and acquisitions, forthcoming therapeutic developments in 2024 focusing on weight loss drugs, and valuations for Novo Nordisk and other players in the weight loss drug market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app